Compile Data Set for Download or QSAR
maximum 50k data
Found 24 Enz. Inhib. hit(s) with all data for entry = 50018320
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194364(4-(4-cinnamamidobutyl)-N-(3,4-dichlorophenyl)-1,4-...)
Affinity DataIC50:  170nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194380(CHEMBL223087 | N-(3,4-dichlorophenyl)-4-(3-(3-(3,4...)
Affinity DataIC50:  320nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194365(CHEMBL219730 | N-(3,4-dichlorophenyl)-4-(6-(3-(3,4...)
Affinity DataIC50:  440nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194374(CHEMBL375397 | N-(3,4-dichlorophenyl)-4-(5-(3-(3,4...)
Affinity DataIC50:  470nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194375(CHEMBL373869 | N-(3,4-dichlorophenyl)-1-(5-(3-(3,4...)
Affinity DataIC50:  630nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194376(CHEMBL221226 | N-(3,4-dichlorophenyl)-4-(4-(3-(3,4...)
Affinity DataIC50:  710nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194370(CHEMBL220954 | N-(3-chloro-4-fluorophenyl)-4-(5-(3...)
Affinity DataIC50:  720nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194363(CHEMBL221442 | N-(3,4-dichlorophenyl)-4-(5-(3-(3,4...)
Affinity DataIC50:  940nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194383(CHEMBL375832 | N-(3-chloro-4-fluorophenyl)-4-(5-(3...)
Affinity DataIC50:  980nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194381(CHEMBL373506 | N-(3-chlorophenyl)-4-(5-(3-(3,4-dic...)
Affinity DataIC50:  1.30E+3nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194372(CHEMBL222729 | N-(4-chloro-3-(trifluoromethyl)phen...)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194367(4-(5-(3-(3,4-dichlorophenyl)acrylamido)pentyl)-N-(...)
Affinity DataIC50:  1.00E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194363(CHEMBL221442 | N-(3,4-dichlorophenyl)-4-(5-(3-(3,4...)
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of human liver GPa in absence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194369(CHEMBL376433 | N-(3,4-dichlorophenyl)-4-(6-(3-(3,4...)
Affinity DataIC50:  2.40E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194368(CHEMBL222125 | N-(4-chloro-3-(trifluoromethyl)phen...)
Affinity DataIC50:  5.10E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194366(CHEMBL373842 | N-(3-chlorophenyl)-4-(5-(3-(3,4-dic...)
Affinity DataIC50:  5.10E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194377(CHEMBL220177 | N-(4-chlorophenyl)-4-(5-(3-(3,4-dic...)
Affinity DataIC50:  5.10E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194385(-N-(benzo[d][1,3]dioxol-5-yl)-4-(5-(3-(3,4-dichlor...)
Affinity DataIC50:  7.00E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194382(CHEMBL223676 | N-(3,4-dichlorophenyl)-4-(2-(3-(3,4...)
Affinity DataIC50:  9.00E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194373(CHEMBL222953 | N-(3,4-dichlorophenyl)-4-(2-(3-(3,4...)
Affinity DataIC50:  1.00E+5nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194379(4-(5-(3-(3,4-dichlorophenyl)acrylamido)pentyl)-N-(...)
Affinity DataIC50:  1.00E+5nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194384(4-(5-(3-(3,4-dichlorophenyl)acrylamido)pentyl)-N-p...)
Affinity DataIC50:  1.00E+5nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194371(4-(5-(3-(3,4-dichlorophenyl)acrylamido)pentyl)-N-p...)
Affinity DataIC50:  1.00E+5nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194378(CHEMBL222126 | N-(4-chlorophenyl)-4-(5-(3-(3,4-dic...)
Affinity DataIC50:  1.00E+5nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed